Showing results (731-740 of 791) with videos related to
Sort By:
Pageof 80
Medrxiv : the Preprint Server for Health Sciences|July 1, 2024
Prediction of future cognitive decline among cognitively unimpaired individuals using measures of soluble phosphorylated tau or tau tangle pathologyRik Ossenkoppele, Gemma Salvadó, Shorena Janelidze, et al.Nature Aging|March 29, 2025
Plasma p-tau217 and tau-PET predict future cognitive decline among cognitively unimpaired individuals: implications for clinical trialsRik Ossenkoppele, Gemma Salvadó, Shorena Janelidze, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 9, 2022
European consensus for the diagnosis of MCI and mild dementia: Preparatory phaseCristina Festari, Federico Massa, Matteo Cotta Ramusino, et al.Journal of Neurology, Neurosurgery, and Psychiatry|January 6, 2025
Tract-specific white matter hyperintensities and neuropsychiatric syndromes: a multicentre memory clinic studyCheuk Ni Kan, Mirthe Coenen, Xin Xu, et al.Brain : a Journal of Neurology|July 30, 2015
Alzheimer's disease cerebrospinal fluid biomarker in cognitively normal subjectsJon B Toledo, Henrik Zetterberg, Argonde C van Harten, et al.The Lancet. Neurology|February 16, 2024
European intersocietal recommendations for the biomarker-based diagnosis of neurocognitive disordersGiovanni B Frisoni, Cristina Festari, Federico Massa, et al.European Journal of Nutrition|May 31, 2020
Dietary patterns are related to cognitive functioning in elderly enriched with individuals at increased risk for Alzheimer's diseaseL M P Wesselman, D Melo van Lent, A Schröder, et al.Nature Medicine|February 16, 2026
A quantitative DOPA decarboxylase biomarker for diagnosis in Lewy body disordersKatharina Bolsewig, Giovanni Bellomo, Yanaika S Hok-A-Hin, et al.Nature Aging|March 12, 2026
Microglia protein profiles in CSF across Alzheimer's disease clinical stagesElena-Raluca Blujdea, Pieter van Bokhoven, Pamela V Martino-Adami, et al.Nature Medicine|April 15, 2026
An acetylated Tau-174 CSF biomarker discriminates between TDP-43 and tau pathology in patients with frontotemporal lobar degenerationMadison I J Honey, Yanaika S Hok-A-Hin, Elisabeth H Thijssen, et al.Pageof 80